Abstract
Between about 1955 and 1970, some 100,000 Japanese were diagnosed as having subacute myelooptic neuropathy (SMON), a new disease characterized by abdominal and neurological manifestations, the former nearly always preceding the latter. Circumstantial evidence obtained in 1969-70 suggested that SMON might have been caused by clioquinol (CQL), a gastrointestinal disinfectant, and led to the suspension of further sales of CQL in Japan. However, several inconsistencies for the CQL theory of SMON have now emerged; first, CQL had been widely used in Japan for nearly 20 years before SMON occurred. Secondly, the SMON epidemic began to subside several months before CQL sales were suspended. Thirdly, a large proportion of SMON patients--probably about one-third and possibly more--had not taken CQL within six months of the onset of the disease (the modal interval between first taking CQL and the onset of SMON being about three weeks, and more than 100 days in only 4% of SMON patients); of the remaining two-thirds or so, many had taken CQL as part of the treatment of the first (that is, abdominal) symptoms of SMON itself. Fourthly, there was no dose-response relationship. Finally, SMON rarely, if ever, occurred outside Japan. CQL could, however, have been involved in the causation of SMON as an optional enhancer of some other necessary cause; the history of post-war environmental pollution in Japan is compatible with this hypothesis. Over-readiness to accept postulated toxic effects of medicines and chemicals as proven is likely to do at least as much harm as good to individual and community health.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Armstrong B., Stevens N., Doll R. Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. Lancet. 1974 Sep 21;2(7882):672–675. doi: 10.1016/s0140-6736(74)93258-9. [DOI] [PubMed] [Google Scholar]
- Doll R. Unwanted effects of drugs. Br Med Bull. 1971 Jan;27(1):25–31. doi: 10.1093/oxfordjournals.bmb.a070809. [DOI] [PubMed] [Google Scholar]
- Feinstein A. R. Clinical biostatistics. 8. An analytic appraisal of the University Group Diabetes Program (UGDP) study. Clin Pharmacol Ther. 1971 Mar-Apr;12(2):167–191. doi: 10.1002/cpt1971122part1167. [DOI] [PubMed] [Google Scholar]
- GHOLZ L. M., ARONS W. L. PROPHYLAXIS AND THERAPY OF AMEBIASIS AND SHIGELLOSIS WITH IODOCHLORHYDROXYQUIN. Am J Trop Med Hyg. 1964 May;13:396–401. doi: 10.4269/ajtmh.1964.13.396. [DOI] [PubMed] [Google Scholar]
- Heinonen O. P., Shapiro S., Tuominen L., Turunen M. I. Reserpine use in relation to breast cancer. Lancet. 1974 Sep 21;2(7882):675–677. doi: 10.1016/s0140-6736(74)93259-0. [DOI] [PubMed] [Google Scholar]
- Kono R. Subacute myelo-optico-neuropathy, a new neurological disease prevailing in Japan. Jpn J Med Sci Biol. 1971 Aug;24(4):195–216. doi: 10.7883/yoken1952.24.195. [DOI] [PubMed] [Google Scholar]
- Mack T. M., Henderson B. E., Gerkins V. R., Arthur M., Baptista J., Pike M. C. Reserpine and breast cancer in a retirement community. N Engl J Med. 1975 Jun 26;292(26):1366–1371. doi: 10.1056/NEJM197506262922603. [DOI] [PubMed] [Google Scholar]
- Smart N. A. Use and residues of mercury compounds in agriculture. Residue Rev. 1968;23:1–36. doi: 10.1007/978-1-4615-8437-7_1. [DOI] [PubMed] [Google Scholar]
- Sobue I., Ando K., Iida M., Takayanagi T., Yamamura Y., Matsuoka Y. Myeloneuropathy with abdominal disorders in Japan. A clinical study of 752 cases. Neurology. 1971 Feb;21(2):168–173. doi: 10.1212/wnl.21.2.168. [DOI] [PubMed] [Google Scholar]
- Spinks A. Future invention in a harsher world. Proc R Soc Med. 1974 Oct;67(10):969–978. [PMC free article] [PubMed] [Google Scholar]
- Symmers W. S. Amphotericin pharmacophobia. Br Med J. 1973 Nov 24;4(5890):460–463. doi: 10.1136/bmj.4.5890.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Trowell J., Peto R., Smith A. C. Controlled trial of repeated halothane anaesthetics in patients with carcinoma of the uterine cervix treated with radium. Lancet. 1975 Apr 12;1(7911):821–824. [PubMed] [Google Scholar]
- Weatherall M. Limitations on the discovery and supply of medicines. Proc R Soc Med. 1974 Dec;67(12 Pt 2):1287–1292. [PMC free article] [PubMed] [Google Scholar]
- Wright R., Eade O. E., Chisholm M., Hawksley M., Lloyd B., Moles T. M., Edwards J. C., GArdner M. J. Controlled prospective study of the effect on liver function of multiple exposures to halothane. Lancet. 1975 Apr 12;1(7911):817–820. doi: 10.1016/s0140-6736(75)93000-7. [DOI] [PubMed] [Google Scholar]